JERE:LSE JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc)

GBX 3,629.00 0.00 0
Icon

JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) (JERE:LSE) Stock Analysis and Price Targets

ETF | Others | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

GBX 3,629.00

0.00 (0.00)%

GBX 1.13B

6.00

GBX -1.00

N/A

Icon

JERE:LSE

JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) (GBX)
ETF | LSE
GBX 3,629.00
0.00 0
Take a Tour

JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) (JERE:LSE) Stock Forecast

N/A

Based on the JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) stock forecast from 0 analysts, the average analyst target price for JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) is not available over the next 12 months. JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) is Slightly Bullish , which is based on 2 positive signals and 1 negative signals. At the last closing, JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc)’s stock price was GBX 3,629.00. JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc)’s stock price has changed by +2.44% over the past week, +0.82% over the past month and +10.72% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...